Endometriosis and SIBO: The Overlap Most Doctors Miss
Research suggests that up to 90% of people with endometriosis experience gastrointestinal symptoms like bloating, constipation, and nausea, and in one 2025 case-control study, nearly 92% of endometriosis patients tested positive for small intestinal bacterial overgrowth (SIBO) or intestinal methanogen overgrowth (IMO), compared with 83% of matched controls.12 The connection isn’t coincidental. Endometriosis is associated with inflammation, disrupted gut motility, and hormonal shifts that can create the environment for bacterial overgrowth in the small intestine — a framework called the gut-pelvic axis.
Jump to section
- How Common Is SIBO in People With Endometriosis?
- What Is SIBO?
- Why Does Endometriosis Increase SIBO Risk?
- What Are the Symptoms That Suggest SIBO?
- How Is SIBO Tested?
- What Are the Treatment Approaches for SIBO?
- Why Can Treating SIBO Ease Endo Belly?
- When to Seek Care
- How Do You Find a Provider Who Treats Both?
You’re lying on the couch after dinner, watching your belly swell like you’re six months pregnant — even though all you ate was a salad. You’ve told your doctor about the bloating dozens of times, but the conversation always dead-ends at "it’s just your endo" or "try a low-FODMAP diet."
How Common Is SIBO in People With Endometriosis?
Up to 90% of people with endometriosis report gastrointestinal symptoms — including bloating, constipation, diarrhea, and nausea — at rates far higher than the general population.1 In one 2025 case-control study of 1,027 women, SIBO/IMO prevalence was 91.9% among endometriosis patients versus 83.1% in age-matched controls, a statistically significant difference.2
What most articles miss is that these two conditions don’t just happen to coexist — they actively fuel each other. Endometriosis creates the conditions for SIBO to develop, and SIBO amplifies the inflammation and bloating that make endometriosis symptoms worse. This bidirectional relationship is what practitioners call the gut-pelvic axis: a framework connecting pelvic inflammation, gut bacteria, intestinal motility, and hormonal cross-talk into one interconnected system.6 If you want a deeper look at how this shows up in the belly, see endo belly: what causes it and how to calm it.
What Is SIBO?
SIBO affects an estimated 2.5–22% of the general population, depending on the testing method used, and that number climbs sharply in people with conditions that slow gut motility.3 In simple terms, SIBO means bacteria that normally live in your large intestine have migrated into your small intestine, where they don’t belong.
Your small intestine is designed to be relatively low in bacteria. It has built-in cleaning mechanisms — waves of muscular contractions called the migrating motor complex (MMC) that sweep bacteria downward roughly every 90 minutes during fasting.3 When those cleaning waves are disrupted, bacteria accumulate, ferment the food you eat, and produce excess gas. That gas is what causes the intense bloating, abdominal distension, and discomfort that can feel indistinguishable from endo belly.
Why Does Endometriosis Increase SIBO Risk?
Gut motility changes
In the same 2025 case-control study, 85.8% of endometriosis patients had altered intestinal transit, compared with 71% of controls.2 Endometriosis-related inflammation may impair the migrating motor complex — those cleaning waves that keep bacteria from accumulating. When motility slows, bacteria have time to settle and multiply in the small intestine. Progesterone, which rises in the second half of the menstrual cycle, also naturally slows gut motility, which may help explain why endo belly often worsens in the luteal phase.1
Inflammation
Endometriosis is a chronic inflammatory disease that elevates cytokines and immune mediators throughout the body — not just in the pelvis.1 This systemic inflammation can increase intestinal permeability (sometimes called "leaky gut"), allowing bacterial byproducts like lipopolysaccharide (LPS) to cross the gut lining and trigger further immune activation. Research suggests this creates a vicious cycle: pelvic inflammation disrupts the gut, and gut disruption worsens pelvic inflammation.6
Surgery and adhesions
Pelvic and abdominal surgeries — including laparoscopic excision for endometriosis — can create adhesions (bands of scar tissue) that kink or partially obstruct the small intestine. The ACG Clinical Guideline on SIBO identifies post-surgical adhesions and anatomical changes as established risk factors for bacterial overgrowth.3 One study found that 37.6% of patients with a history of abdominal surgery tested positive for SIBO, compared with 13.3% of controls.3 This doesn’t mean you should avoid necessary surgery — it means post-surgical gut health deserves attention.
Hormonal factors
A key piece of the puzzle is the estrobolome — a collection of gut bacteria that help metabolize estrogen.6 When gut bacteria are out of balance, the estrobolome can recirculate a significant proportion of estrogen back into circulation instead of clearing it. Because endometriosis is estrogen-dependent, this excess estrogen may contribute to lesion growth, which in turn is linked to more inflammation and more gut disruption. Recent reviews of the endometriosis microbiome literature have documented consistent differences in gut microbiota diversity between women with and without endometriosis, though the estrobolome’s exact role in endometriosis is still being studied.6
The insight most articles skip: GI doctors tend to treat SIBO as a standalone gut problem, and gynecologists tend to treat endo belly as a standalone pelvic problem. But the gut-pelvic axis means these are the same problem viewed from two different angles. Motility, microbiome, hormones, and inflammation are all talking to each other — and effective treatment needs to address the whole conversation.
What Are the Symptoms That Suggest SIBO?
In the 2025 case-control study, 67.8% of endometriosis patients with SIBO reported constipation, compared with 44.7% of those without endometriosis, and dizziness was also significantly more common (44.8% vs. 28.7%).2 Symptoms that may point to SIBO on top of your endometriosis include:
- Bloating that worsens within 30–90 minutes of eating
- Excessive gas and belching
- Alternating constipation and diarrhea
- Bloating that doesn’t follow your menstrual cycle pattern (endo belly typically worsens premenstrually, while SIBO bloating is more constant)
- Nausea or acid reflux
- Fatigue and brain fog
- Symptoms that don’t fully improve with hormonal endo treatments
What other blogs get wrong: Many articles list bloating as the hallmark SIBO symptom, but AGA expert consensus notes that diarrhea — not bloating — actually has the strongest association with SIBO.4 If you have unexplained loose stools alongside your endo symptoms, that is an important clue worth flagging to your provider.
How Is SIBO Tested?
The gold standard for SIBO diagnosis is a small bowel aspirate and culture, but this requires an endoscopy and is rarely used in practice.3 The most common clinical test is a breath test — either a lactulose or glucose breath test — which measures hydrogen and methane gases produced by bacteria after you drink a sugar solution.
You fast overnight, drink the solution, and breathe into collection tubes every 15–20 minutes for about 90 minutes. A rise in hydrogen of ≥20 parts per million (ppm) above baseline within 90 minutes suggests SIBO. A methane level ≥10 ppm at any point suggests intestinal methanogen overgrowth (IMO), which is more closely linked to constipation.3 In the 2025 endometriosis study, methane overgrowth accounted for roughly 63% of positive results in endo patients — a pattern that aligns with the constipation-predominant symptoms many people with endometriosis report.2
What Are the Treatment Approaches for SIBO?
A single 7- to 10-day course of antibiotics improves symptoms in 46–90% of SIBO patients and normalizes breath tests in 20–75%.3 The most studied antibiotic is rifaximin, a gut-targeted antibiotic with a roughly 70% eradication rate in a meta-analysis of 32 clinical trials.5 ACG guidelines recommend rifaximin 550 mg three times daily for 14 days as first-line therapy.3
For methane-dominant overgrowth (IMO) — which is common in endometriosis — a combination of rifaximin plus neomycin may be more effective, because methane-producing archaea don’t respond as well to rifaximin alone.3 Beyond antibiotics, treatment should address the underlying reasons SIBO developed:
- Prokinetic agents to restore the migrating motor complex and prevent recurrence
- Dietary modifications such as a short-term low-FODMAP or elemental diet to reduce fermentable substrates
- Addressing hormonal drivers through coordinated endometriosis management
- Probiotics, which have shown promise in reducing endometriosis-associated symptoms in early research, though clinical trial data remain limited6
Recurrence is common — up to 44% within 9 months — which is why treating the root causes (motility, inflammation, hormonal imbalance) matters as much as the antibiotic itself.3 For overlap with IBS symptoms, see endometriosis and IBS: the gut-pelvic connection.
Why Can Treating SIBO Ease Endo Belly?
When SIBO is contributing to your bloating, treating it can provide significant relief — but the key word is contributing. Endo belly has multiple drivers, including pelvic inflammation, fluid retention, and visceral hypersensitivity (a lower pain threshold in the intestinal wall). SIBO adds bacterial gas production on top of all of that.16
What other blogs get wrong: Many suggest that treating SIBO will "cure" endo belly. It won’t — but it can remove one major layer of the problem. Think of it as turning down one of several volume knobs. When you reduce the bacterial gas production, the remaining symptoms become more manageable and more responsive to endo-specific treatments. For day-of flare-ups, see how to stop an endometriosis flare fast.
When to Seek Care
Contact a provider if you experience:
- Abdominal pain rated 7/10 or higher that doesn’t respond to your usual management
- Fever above 100.4°F (38°C) with abdominal symptoms
- Unintentional weight loss of more than 5% of body weight over 6–12 months
- Persistent diarrhea lasting more than 4 weeks
- Signs of nutritional deficiency (unusual fatigue, numbness or tingling, easy bruising)
- Bloating so severe it interferes with eating, sleeping, or daily activities
These symptoms may indicate SIBO, but they can also signal other conditions that need evaluation.
How Do You Find a Provider Who Treats Both?
Most endometriosis patients wait an average of 7–10 years for a diagnosis.1 Adding SIBO to the picture requires a provider who can see both the pelvic and the gut sides of the equation. Based on current evidence, endometriosis does not directly "cause" SIBO — but it is associated with a constellation of risk factors (impaired motility, chronic inflammation, surgical adhesions, and hormonal disruption) that make SIBO significantly more likely to develop.23 Treating the endo without addressing the gut, or treating the gut without addressing the endo, often leaves patients stuck in a cycle of partial improvement and frustrating recurrence. If gut symptoms are showing up with nervous-system flare-ups too, see endometriosis and nervous system dysregulation.
Frequently Asked Questions
Can endometriosis cause SIBO?
Endometriosis does not directly cause SIBO, but it is associated with multiple risk factors — impaired gut motility, chronic inflammation, surgical adhesions, and hormonal disruption — that significantly increase the likelihood of developing bacterial overgrowth. In one 2025 case-control study, 91.9% of endometriosis patients tested positive for SIBO or IMO, compared with 83.1% of matched controls.2
How is SIBO tested?
The most common test is a lactulose or glucose breath test, which measures hydrogen and methane gases over about 90 minutes after drinking a sugar solution. A hydrogen rise of ≥20 ppm above baseline within 90 minutes suggests SIBO, and a methane level ≥10 ppm at any point suggests intestinal methanogen overgrowth.3
Does treating SIBO help endo belly?
Treating SIBO can significantly reduce bloating by eliminating excess bacterial gas production, but endo belly has multiple drivers — including pelvic inflammation and visceral hypersensitivity. SIBO treatment removes one important layer, which is why an integrated approach usually works better than treating either problem alone.1
What is the link between endometriosis and the gut microbiome?
Recent reviews have documented consistent differences in gut microbiota diversity between women with and without endometriosis. The estrobolome — gut bacteria that metabolize estrogen — plays a key role, because dysbiosis can lead to excess estrogen recirculation that may contribute to endometriosis.6
Can surgery cause SIBO?
Yes. Pelvic and abdominal surgeries can create adhesions that partially obstruct the small intestine, and one study found 37.6% of post-surgical patients tested positive for SIBO compared with 13.3% of controls. The ACG Clinical Guideline identifies post-surgical adhesions as an established SIBO risk factor.3
Ready for a specialist who treats the whole picture?
A $149 Comprehensive Assessment is a 45-minute telehealth visit that maps your pain drivers across six systems, plus a personalized Endo Pain Signature report delivered within 24 hours. IL, CO, and TX.
Book Your $149 Assessment →References
- Taylor HS, Kotlyar AM, Flores VA. Endometriosis Is a Chronic Systemic Disease: Clinical Challenges and Novel Innovations. Lancet. 2021;397(10276):839-852. doi:10.1016/S0140-6736(21)00389-5.
- Halfon J, et al. Small Intestinal Bacterial Overgrowth and Intestinal Methanogen Overgrowth in Women With Endometriosis: A Case-Control Study. International Journal of Gynecology & Obstetrics. 2025. [Exact citation pending verification — please confirm full author list, volume, and DOI before publishing.]
- Pimentel M, Saad RJ, Long MD, Rao SSC. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. American Journal of Gastroenterology. 2020;115(2):165-178. doi:10.14309/ajg.0000000000000501.
- Shah A, Talley NJ, Jones M, et al. Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies. American Journal of Gastroenterology. 2020;115(2):190-201. doi:10.14309/ajg.0000000000000504.
- Gatta L, Scarpignato C. Systematic Review With Meta-Analysis: Rifaximin Is Effective and Safe for the Treatment of Small Intestinal Bacterial Overgrowth. Alimentary Pharmacology & Therapeutics. 2017;45(5):604-616. doi:10.1111/apt.13928.
- Qin R, Tian G, Liu J, Cao L. The Gut Microbiota and Endometriosis: From Pathogenesis to Diagnosis and Treatment. Frontiers in Cellular and Infection Microbiology. 2022;12:1069557. doi:10.3389/fcimb.2022.1069557.
The content on this page is for educational purposes only and is not medical advice. Always consult your healthcare provider for individualized guidance. Read our editorial policy.